McCourt Marion
SEC CIK 1663758 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | EVP Commercial | 12.0K | — | $30.76M | 92 | 2021-07-01 | 2026-09-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
Transactions 92
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-03 16:50 | 2026-09-02+ | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $853.56 | -2,346 | 12.0K | -16% | -$2.00M |
| 2025-12-11 | 2025-12-09 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $701.51 | -1,021 | 14.3K | -7% | -$716.2K | |
| D | 2025-12-09 | 2025-12-05 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +2,476 | 16.7K | +17% | $0 |
| D | 2025-12-09 | 2025-12-08 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $712.94 | -1,336 | 15.4K | -8% | -$952.5K |
| 2024-12-18 | 2024-12-16 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $730.81 | -759 | 14.2K | -5% | -$554.7K | |
| D | 2024-12-10 | 2024-12-09 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $787.00 | -274 | 15.0K | -2% | -$215.6K |
| D | 2024-12-10 | 2024-12-06 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +2,332 | 15.3K | +18% | $0 |
| D | 2024-11-05 | 2024-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $844.61 | -1,000 | 12.9K | -7% | -$844.6K |
| D | 2024-11-05 | 2024-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $381.40 | +1,000 | 13.9K | +8% | +$381.4K |
| D | 2024-10-03 | 2024-10-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $1,054.06 | -1,000 | 12.9K | -7% | -$1.05M |
| D | 2024-10-03 | 2024-10-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $381.40 | +1,000 | 13.9K | +8% | +$381.4K |
| D | 2024-09-05 | 2024-09-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $1,178.73 | -1,000 | 12.9K | -7% | -$1.18M |
| D | 2024-09-05 | 2024-09-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $381.40 | +1,000 | 13.9K | +8% | +$381.4K |
| D | 2024-08-05 | 2024-08-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,137 | 14.1K | +9% | +$423.5K |
| D | 2024-08-05 | 2024-08-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $1,060.86 | -1,137 | 12.9K | -8% | -$1.21M |
| D | 2024-07-02 | 2024-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,137 | 14.1K | +9% | +$423.5K |
| D | 2024-07-02 | 2024-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $1,047.11 | -1,137 | 12.9K | -8% | -$1.19M |
| D | 2024-06-05 | 2024-06-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,138 | 14.1K | +9% | +$423.9K |
| D | 2024-06-05 | 2024-06-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $980.16 | -1,138 | 12.9K | -8% | -$1.12M |
| 2024-05-03 | 2024-05-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $889.41 | -250 | 12.9K | -2% | -$222.4K | |
| 2024-04-03 | 2024-04-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $964.73 | -250 | 13.2K | -2% | -$241.2K | |
| 2024-03-05 | 2024-03-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $967.50 | -358 | 13.4K | -3% | -$346.4K | |
| 2024-02-06 | 2024-02-05 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $934.71 | -1,000 | 13.8K | -7% | -$934.7K | |
| 2024-02-02 | 2024-02-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $945.61 | -273 | 14.8K | -2% | -$258.2K | |
| 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $873.91 | -274 | 15.1K | -2% | -$239.5K | |
| 2023-12-14 | 2023-12-12 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $856.71 | -5,105 | 15.3K | -25% | -$4.37M | |
| D | 2023-12-12 | 2023-12-11 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $838.44 | -270 | 20.8K | -1% | -$226.4K |
| D | 2023-12-12 | 2023-12-08 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +2,133 | 21.1K | +11% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $843.88 | -1,225 | 20.4K | -6% | -$1.03M |
| D | 2023-11-02 | 2023-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $381.40 | +1,000 | 20.8K | +5% | +$381.4K |
| D | 2023-11-02 | 2023-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $783.91 | -1,000 | 19.8K | -5% | -$783.9K |
| D | 2023-10-03 | 2023-10-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $827.00 | -1,038 | 19.8K | -5% | -$858.4K |
| D | 2023-10-03 | 2023-10-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,038 | 20.8K | +5% | +$386.6K |
| 2023-09-06 | 2023-09-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $834.55 | -250 | 19.8K | -1% | -$208.6K | |
| 2023-08-03 | 2023-08-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $744.66 | -250 | 20.1K | -1% | -$186.2K | |
| 2023-07-06 | 2023-07-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $710.09 | -250 | 20.3K | -1% | -$177.5K | |
| 2023-06-02 | 2023-06-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $736.00 | -250 | 20.6K | -1% | -$184.0K | |
| D | 2023-04-05 | 2023-04-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 21.9K | +5% | +$409.7K |
| D | 2023-04-05 | 2023-04-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $818.80 | -1,100 | 20.8K | -5% | -$900.7K |
| D | 2023-03-03 | 2023-03-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $759.89 | -1,100 | 20.8K | -5% | -$835.9K |
| D | 2023-03-03 | 2023-03-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 21.9K | +5% | +$409.7K |
| 2023-02-14 | 2023-02-12 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $751.78 | -1,276 | 20.8K | -6% | -$959.3K | |
| D | 2023-02-08 | 2023-02-07 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,000 | 23.1K | +5% | +$372.5K |
| D | 2023-02-08 | 2023-02-07 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $769.04 | -1,000 | 22.1K | -4% | -$769.0K |
| D | 2023-02-03 | 2023-02-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 23.2K | +5% | +$409.7K |
| D | 2023-02-03 | 2023-02-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $752.19 | -1,100 | 22.1K | -5% | -$827.4K |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $721.86 | -1,100 | 22.1K | -5% | -$794.0K |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 23.2K | +5% | +$409.7K |
| D | 2022-12-20 | 2022-12-16 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +2,973 | 22.1K | +16% | $0 |
| 2022-12-13 | 2022-12-09 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $753.28 | -274 | 19.4K | -1% | -$206.4K | |
| 2022-12-13 | 2022-12-12 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $730.17 | -264 | 19.1K | -1% | -$192.8K | |
| D | 2022-12-02 | 2022-12-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $756.19 | -1,100 | 19.6K | -5% | -$831.8K |
| D | 2022-12-02 | 2022-12-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 20.7K | +6% | +$409.7K |
| D | 2022-11-07 | 2022-11-04 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,000 | 20.6K | +5% | +$372.5K |
| D | 2022-11-07 | 2022-11-04 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $727.82 | -1,000 | 19.6K | -5% | -$727.8K |
| D | 2022-11-02 | 2022-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,100 | 20.7K | +6% | +$409.7K |
| D | 2022-11-02 | 2022-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $750.00 | -1,100 | 19.6K | -5% | -$825.0K |
| DM | 2022-10-05 | 2022-10-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $705.39 | -1,100 | 19.6K | -5% | -$775.9K |
| DM | 2022-10-05 | 2022-10-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $359.04 | +1,100 | 20.2K | +6% | +$394.9K |
| D | 2022-09-02 | 2022-09-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,100 | 20.7K | +6% | +$377.2K |
| D | 2022-09-02 | 2022-09-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $577.62 | -1,100 | 19.6K | -5% | -$635.4K |
| D | 2022-08-02 | 2022-08-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,100 | 20.7K | +6% | +$377.2K |
| D | 2022-08-02 | 2022-08-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $581.53 | -1,100 | 19.6K | -5% | -$639.7K |
| D | 2022-07-05 | 2022-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,100 | 20.7K | +6% | +$377.2K |
| D | 2022-07-05 | 2022-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $587.76 | -1,100 | 19.6K | -5% | -$646.5K |
| D | 2022-06-03 | 2022-06-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $669.51 | -1,100 | 19.6K | -5% | -$736.5K |
| D | 2022-06-03 | 2022-06-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,100 | 20.7K | +6% | +$377.2K |
| D | 2022-05-03 | 2022-05-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,100 | 20.7K | +6% | +$377.2K |
| D | 2022-05-03 | 2022-05-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $656.97 | -1,100 | 19.6K | -5% | -$722.7K |
| D | 2022-04-04 | 2022-04-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-04-04 | 2022-04-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $701.82 | -1,000 | 19.6K | -5% | -$701.8K |
| D | 2022-03-03 | 2022-03-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-03-03 | 2022-03-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $615.39 | -1,000 | 19.6K | -5% | -$615.4K |
| D | 2022-02-02 | 2022-02-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-02-02 | 2022-02-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $607.46 | -1,000 | 19.6K | -5% | -$607.5K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $625.00 | -1,000 | 19.6K | -5% | -$625.0K |
| 2021-12-14 | 2021-12-11 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | F - Tax | $664.34 | -388 | 20.0K | -2% | -$257.8K | |
| 2021-12-14 | 2021-12-13 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale | $653.12 | -344 | 19.6K | -2% | -$224.7K | |
| D | 2021-12-10 | 2021-12-08 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +3,338 | 20.4K | +20% | $0 |
| D | 2021-12-02 | 2021-12-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $639.13 | -1,000 | 17.0K | -6% | -$639.1K |
| D | 2021-12-02 | 2021-12-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-11-03 | 2021-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-11-03 | 2021-11-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $640.00 | -1,000 | 17.0K | -6% | -$640.0K |
| D | 2021-10-04 | 2021-10-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-10-04 | 2021-10-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $576.75 | -1,000 | 17.0K | -6% | -$576.8K |
| D | 2021-09-03 | 2021-09-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-09-03 | 2021-09-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $674.72 | -1,000 | 17.0K | -6% | -$674.7K |
| D | 2021-08-04 | 2021-08-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-08-04 | 2021-08-02 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $577.12 | -1,000 | 17.0K | -6% | -$577.1K |
| D | 2021-07-02 | 2021-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| D | 2021-07-02 | 2021-07-01 | REGN | Regeneron Pharmaceuticals | McCourt Marion | EVP Commercial | S - Sale+OE | $556.60 | -1,000 | 17.0K | -6% | -$556.6K |
Purchase Sale Sale after option exercise All abbreviations